• 1
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of osteoporosis. J Bone Miner Res 9:11371141.
  • 2
    Torgerson DJ, Campbell MK, Thomas RE, Reid DM 1996 Prediction of perimenopausal fractures by BMD and other risk factors. J Bone Miner Res 11:293297.
  • 3
    Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767773.
  • 4
    Ross PD, Davis JW, Epstein RS, Wasnich RD 1991 Preexisting fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919923.
  • 5
    Ralston SH 1997 The genetics of osteoporosis. QJM 90:247251.
  • 6
    Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G 1995 Segregation analysis and variance components analysis of BMD in healthy families. J Bone Miner Res 12:20172022.
  • 7
    Kelly PJ, Nguyen T, Hopper J, Pocock N, Sambrook P, Eisman J 1993 Changes in axial bone density with age: A twin study. J Bone Miner Res 8:1117.
  • 8
    Christian JC, Yu PL, Slemenda CW, Johnston CC 1989 Heritability of bone mass: A longitudinal study in aging male twins. Am J Hum Genet 44:429433.
  • 9
    Ferrari S, Rizzoli R, Chevally T, Slosman D, Eisman JA, Bonjour J-P 1995 Vitamin D receptor gene polymorphisms and change in lumbar spine BMD. Lancet 345:423424.
  • 10
    Kikuchi R, Uemura T, Gorai I, Ohno S, Minaguchi H 1999 Early and late postmenopausal bone loss is associated with BsmI vitamin D receptor gene polymorphism in Japanese women. Calcif Tissue Int 64:102106.
  • 11
    Krall EA, Parry P, Lichter JB, Dawson-Hughes B 1995 Vitamin D receptor alleles and rates of bone loss: Influence of years since menopause and calcium intake. J Bone Miner Res 10:978984.
  • 12
    Deng HW, Li J, Li JL, Johnson M, Gong G, Recker RR 1999 Association of VDR and estrogen receptor genotypes with bone mass in postmenopausal white women: Different conclusions with different analyses and the implications. Osteoporos Int 9:499507.
  • 13
    Giguere Y, Dodin S, Blanchet C, Morgan K, Rousseau F 2000 The association between heel ultrasound and hormone replacement therapy is modulated by a two-locus vitamin D and estrogen receptor genotype. J Bone Miner Res 15:10761084.
  • 14
    Kurabayashi T, Tomita M, Matsushita H, Yahata T, Honda A, Takakuwa K, Tanaka K 1999 Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on BMD in Japanese women. Am J Obstet Gynecol 180:11151120.
  • 15
    Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, Saarikoski S, Honkanen R, Maenpaa PH 2000 Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy. J Bone Miner Res 15:315321.
  • 16
    Weichetova M, Stepan JJ, Michalska D, Haas T, Pols HA, Uitterlinden AG 2000 COL1A1 polymorphism contributes to BMD to assess prevalent wrist fractures. Bone 26:287290.
  • 17
    Sainz J, Van Tornout JM, Sayre J, Kaufman F, Gilsanz V 1999 Association of collagen type 1 alpha1 gene polymorphism with bone density in early childhood. J Clin Endocrinol Metab 84:853855.
  • 18
    McGuigan FEA, Reid DM, Ralston SH 1999 Susceptibility to osteoporotic fracture is determined by allelic variation at the Sp1 site, rather than other polymorphic sites, at the COL1A1 locus. Osteoporos Int 15:338342.
  • 19
    Keen RW, Woodford-Richens KL, Grant SFA, Ralston SH, Lanchbury JS, Spector TD 1999 Polymorphism at the type I collagen COL1A1 locus is associated with reduced BMD, increased fracture risk and increased collagen turnover. Arthritis Rheum 42:285290.
  • 20
    Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, Ralston SH 1998 BMD, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 41:13141320.
  • 21
    Langdahl BL, Ralston SH, Grant SFA, Eriksen EF 1998 An Sp1 binding site polymorphism in the COL1A1 gene predicts osteoporotic fractures in men and women. J Bone Miner Res 13:13841389.
  • 22
    Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FEA, Grant SFA, Hofman A, Van LEEUWEN JPTM, Pols HAP, Ralston SH 1998 Relation of alleles of the collagen type I α 1 gene to bone density and risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:10161022.
  • 23
    Garnero P, Borel O, Grant SFA, Ralston SH, Delmas PD 1998 Collagen I α 1 polymorphism, bone mass and bone turnover in healthy French pre-menopausal women: The OFELY Study. J Bone Miner Res 13:813818.
  • 24
    Roux C, Dougados M, Abel L, Mercier G, Lucotte G 1998 Association of a polymorphism in the collagen I α 1 gene with osteoporosis in French women. Arthritis Rheum 41:187188.
  • 25
    Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH 1996 Reduced bone density and osteoporosis associated with a polymorphic Sp1 site in the collagen type I alpha 1 gene. Nat Genet 14:203205.
  • 26
    Harris SS, Patel MS, Cole DE, Dawson-Hughes B 2000 Associations of the collagen type I alpha1 Sp1 polymorphism with five-year rates of bone loss in older adults. Calcif Tissue Int 66:268271.
  • 27
    Heegaard A, Jorgensen HL, Vestergaard AW, Hassager C, Ralston SH 2000 Lack of influence of collagen type I alpha1 Sp1 binding site polymorphism on the rate of bone loss in a cohort of postmenopausal Danish women followed for 18 years. Calcif Tissue Int 66:409413.
  • 28
    New SA, Bolton-Smith C, Grub DA, Reid DM 1997 Nutritional influences on BMD: A cross-sectional study in premenopausal women. Am J Clin Nutr 65:18311839.
  • 29
    New SA, Robins SP, Campbell MK, Martin JC, Garton MJ, Bollon-Smith C, Grubb DA, Lee SJ, Reid DM 2000 Dietary influences on bone metabolism—further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr 71:142151.
  • 30
    Garton MJ, Torgerson DJ, Donaldson C, Russell IT, Reid DM 1992 Recruitment techniques for screening program: Trial of a new method within a regional osteoporosis study. BMJ 305:8284.
  • 31
    Torgerson DJ, Garton MJ, Donaldson C, Russell IT, Reid DM 1993 Recruitment methods for screening program II: Trial of an improved method within a regional osteoporosis study. BMJ 307:99.
  • 32
    Tunstall-Pedoe H, Smith WCS, Crombie IK, Tavendale R. 1989 Coronary risk factor and lifestyle variation across Scotland: Results from the Scottish Heart Health Study. Scott Med J 34:556560.
  • 33
    Black AE, Coward WA, Cole CJ, Prentice AM 1996 Human energy expenditure in affluent societies: An analysis of 574 doubly labeled water measurements. Eur J Clin Nutr 50:7292.
  • 34
    Hustmyer FG, Lui G, Johnston CC, Christian J, Peacock M 1999 Polymorphism at an Sp1 binding site of COL1A1 and BMD in premenopausal female twins and elderly fracture patients. Osteoporos Int 9:346350.
  • 35
    Liden M, Wilen B, Ljunghall S, Melhus H 1998 Polymorphism at the Sp 1 binding site in the collagen type I alpha 1 gene does not predict BMD in postmenopausal women in Sweden. Calcif Tissue Int 63:293295.
  • 36
    Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD 1993 Effects of spinal osteophytosis on BMD measurements in vertebral osteoporosis. BMJ 307:172173.
  • 37
    Dean V, Hobson EE, Aspden RM, Robins SP, Ralston SH 1998 Relationship between COL1A1 Sp1alleles, gene transcription, collagen production and bone strength. Bone 23:S161.